文献速递运动医学关节外科

用于前交叉韧带损伤后创伤性骨关节炎人源细胞治疗转化研究的猪模型

A Translational Porcine Model for Human Cell-Based Therapies in the Treatment of Posttraumatic Osteoarthritis After Anterior Cruciate Ligament Injury.
PubMed 文献 · Am J Sports Med · 2020-09-14

该描述性实验室研究对9只尤卡坦迷你猪行单侧前交叉韧带离断,纵向检测滑液、血清和尿液中IL-1β与胶原降解,并在伤后4周或12周进行MRI和组织学分析。另3只在伤后2天关节腔内注射107个人骨髓间充质干细胞(hBM-MSCs)联合纤维蛋白载体,评估细胞存活与定位。结果显示伤后4周即可检测到创伤性骨关节炎,伤后12周在大体及组织学上均可检测到骨关节炎;hBM-MSCs可在不免疫抑制的猪膝关节内存活并表达转基因至少2周。

要点

  • 猪前交叉韧带离断后4周即可检测到创伤性骨关节炎,12周时大体及组织学均可检测到骨关节炎。
  • 伤后滑液中IL-1β短暂升高并于2周内消退,滑液和血清中II型胶原蛋白片段升高。
  • hBM-MSCs在不免疫抑制的猪膝关节内存活并表达转基因至少2周。

核心结论

  • 该研究证明在大动物模型中可重现前交叉韧带损伤后与创伤性骨关节炎一致的软骨改变、关节内细胞因子变化和体液生物标志物发现。
  • 研究证明hBM-MSCs可在不免疫抑制的猪膝关节内存活并表达转基因至少2周。

研究设计与样本

  • 描述性实验室研究,9只尤卡坦迷你猪行单侧前交叉韧带离断,监测至伤后12周,伤后4周(n=3)或12周(n=3)处死行MRI和组织学分析。
  • 另3只在伤后2天关节腔内注射107个人骨髓间充质干细胞联合纤维蛋白载体,于注射后第0天(n=1)或第14天(n=2)处死评估。

主要发现

  • 创伤性骨关节炎最早在伤后4周检测到,伤后12周在大体及组织学分析上均可检测到骨关节炎。
  • 滑液分析显示前交叉韧带损伤后不久IL-1β升高,随后在伤后2周消退。
  • 伤后滑液和血清中II型胶原蛋白片段升高。
  • hBM-MSCs-Luc在注射后即刻及注射后2周通过荧光成像、MRI和生物发光成像检测到。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a high incidence of posttraumatic osteoarthritis (PTOA) after anterior cruciate ligament (ACL) injury, and these injuries represent an enormous health care economic burden. In an effort to address this unmet clinical need, there has been increasing interest in cell-based therapies. PURPOSE: To establish a translational large animal model of PTOA and demonstrate the feasibility of intra-articular human cell-based interventions. STUDY DESIGN: Descriptive laboratory study. METHODS: Nine Yucatan mini-pigs underwent unilateral ACL transection and were monitored for up to 12 weeks after injury. Interleukin 1 beta (IL-1β) levels and collagen breakdown were evaluated longitudinally using enzyme-linked immunosorbent assays of synovial fluid, serum, and urine. Animals were euthanized at 4 weeks (n = 3) or 12 weeks (n = 3) after injury, and injured and uninjured limbs underwent magnetic resonance imaging (MRI) and histologic analysis. At 2 days after ACL injury, an additional 3 animals received an intra-articular injection of 107 human bone marrow-derived mesenchymal stem cells (hBM-MSCs) combined with a fibrin carrier. These cells were labeled with the luciferase reporter gene (hBM-MSCs-Luc) as well as fluorescent markers and intracellular iron nanoparticles. These animals were euthanized on day 0 (n = 1) or day 14 (n = 2) after injection. hBM-MSC-Luc viability and localization were assessed using ex vivo bioluminescence imaging, fluorescence imaging, and MRI. RESULTS: PTOA was detected as early as 4 weeks after injury. At 12 weeks after injury, osteoarthritis could be detected grossly as well as on histologic analysis. Synovial fluid analysis showed elevation of IL-1β shortly after ACL injury, with subsequent resolution by 2 weeks after injury. Collagen type II protein fragments were elevated in the synovial fluid and serum after injury. hBM-MSCs-Luc were detected immediately after injection and at 2 weeks after injection using fluorescence imaging, MRI, and bioluminescence imaging. CONCLUSION: This study demonstrates the feasibility of reproducing the chondral changes, intra-articular cytokine alterations, and body fluid biomarker findings consistent with PTOA after ACL injury in a large animal model. Furthermore, we have demonstrated the ability of hBM-MSCs to survive and express transgene within the knee joint of porcine hosts without immunosuppression for at least 2 weeks. CLINICAL RELEVANCE: This model holds great potential to significantly contribute to investigations focused on the development of cell-based therapies for human ACL injury-associated PTOA in the future (see Appendix Figure A1, available online).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Kremen TJ, Stefanovic T, Tawackoli W, et al. A Translational Porcine Model for Human Cell-Based Therapies in the Treatment of Posttraumatic Osteoarthritis After Anterior Cruciate Ligament Injury. Am J Sports Med. 2020. PMID: 32924528. doi:10.1177/0363546520952353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。